Similar Items: Early predictors of 6-month thyroid-stimulating antibody levels after radioactive iodine therapy for Graves' disease: implications for pregnancy planning
- Differentiating TRAb-positive painless thyroiditis from Graves' disease using biochemical and ultrasound findings
- Association of hypothyroidism with adverse pregnancy outcomes: a single-center cohort study in an iodine-sufficient country
- Mean Platelet Volume in Hyperthyroid Toxic Adenoma Patients after Radioactive 131I Treatment
- Recognising pituitary and thyroid dysfunction after craniospinal radiotherapy: an underrecognised mixed endocrine toxicity
- Lugol’s Iodine as a Key Treatment in Transient Gestational Thyrotoxicosis: A Case Report
- Measuring Quality in Thyroid Cancer Surgery